Search

Your search keyword '"Thermochemotherapy"' showing total 139 results

Search Constraints

Start Over You searched for: Descriptor "Thermochemotherapy" Remove constraint Descriptor: "Thermochemotherapy"
139 results on '"Thermochemotherapy"'

Search Results

1. Efficacy and tolerance of hyperthermic intravesical chemotherapy (HIVEC) according to the number of instillations administered.

3. ROS‐Sp1 axis is involved in thermochemotherapy‐enhanced sensitivity of pancreatic cancer cells to gemcitabine.

4. Thermochemotherapy Meets Tissue Engineering for Rheumatoid Arthritis Treatment.

5. Efficacy analysis of a novel thermochemotherapy scheme with pirarubicin for intermediate- and high-risk nonmuscle-invasive bladder cancer: a single-institution nonrandomized concurrent controlled trial

6. A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy.

8. Characterizing Thermal Augmentation of Convection-Enhanced Drug Delivery with the Fiberoptic Microneedle Device

9. Treatment options in non-muscle-invasive bladder cancer after BCG failure

10. A multifunctional ternary Cu(II)-carboxylate coordination polymeric nanocomplex for cancer thermochemotherapy.

11. PALLIATIVE TREATMENT USING THERMOCHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED REGIONAL METASTASES FROM MALIGNANT HEAD AND NECK TUMORS

14. Mussel-inspired PLGA/polydopamine core-shell nanoparticle for light induced cancer thermochemotherapy.

15. [Evaluation of the efficacy and safety of HIVEC intravesical thermochemotherapy with intermediate-risk and high-risk non-muscle-invasive bladder cancer].

16. Cu(II) doped polyaniline nanoshuttles for multimodal tumor diagnosis and therapy.

17. Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.

18. Effects of hyperthermia in neutralising mechanisms of drug resistance in non-muscle-invasive bladder cancer.

19. Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations.

20. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer.

21. Hyperthermia for non-muscle invasive bladder cancer.

22. Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I-II study.

23. Human-Serum-Albumin-Coated Prussian Blue Nanoparticles as pH-/Thermotriggered Drug-Delivery Vehicles for Cancer Thermochemotherapy.

24. The effect of thermochemotherapy with mitomycin C on normal bladder urothelium, an experimental study.

25. Hyperthermia for deep seated tumours – possibilities of heating with capacitive devices

26. Treatment options in non-muscle-invasive bladder cancer after BCG failure.

27. Is thermochemotherapy with the Synergo system a viable treatment option in patients with recurrent non-muscle-invasive bladder cancer?

28. A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy

29. Authors′ Reply

30. pH- and thermosensitive thin lipid layer coated mesoporous magnetic nanoassemblies as a dual drug delivery system towards thermochemotherapy of cancer.

31. Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer.

32. Tumor Theranostics of Transition Metal Ions Loaded Polyaminopyrrole Nanoparticles

33. Enhancement of osteosarcoma cell sensitivity to cisplatin using paclitaxel in the presence of hyperthermia.

34. Quercetin Liposome Sensitizes Colon Carcinoma to Thermotherapy and Thermochemotherapy in Mice Models.

35. Ruolo della chemio-ipertermia endocavitaria a microonde nel trattamento delle neoplasie vescicali non muscolo invasive. Una revisione sistematica della letteratura.

36. Terapia endovescicale di seconda linea. Qual è il ruolo attuale delle terapie device-assisted?

37. Methotrexate-conjugated magnetic nanoparticles for thermochemotherapy and magnetic resonance imaging of tumor.

38. Thermochemotherapy for Non-Muscle-Invasive Bladder Cancer: Is There a Chance to Avoid Early Cystectomy?

40. Analysis of thermochemotherapy-induced apoptosis and the protein expressions of Bcl-2 and Bax in maxillofacial squamous cell carcinomas.

41. The Role of a Combined Regimen With Intravesical Chemotherapy and Hyperthermia in the Management of Non-muscle-invasive Bladder Cancer: A Systematic Review

42. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder

43. Fever-range whole body thermotherapy combined with oxaliplatin: A curative regimen in a pre-clinical breast cancer model.

44. Thermochemotherapy of lower lip squamous cell carcinoma without metastases: An experience of 31 cases.

45. Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo® working party.

46. The importance of schedule in whole body thermochemotherapy.

47. Prediction of anti-tumour effect of thermochemotherapy with in vitro thermochemosensitivity testing for non-small cell lung cancer.

48. High-risk soft tissue sarcoma: Clinical trial and hyperthermia combined chemotherapy.

49. NIR responsive liposomal system for rapid release of drugs in cancer therapy

50. Assessment of hearing in very young children receiving carboplatin for retinoblastoma

Catalog

Books, media, physical & digital resources